175 related articles for article (PubMed ID: 21365239)
1. The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis.
Seo EH; Kim TO; Kim TG; Joo HR; Park J; Park SH; Yang SY; Moon YS; Park MJ; Ryu DY; Song GA
Dig Dis Sci; 2011 Sep; 56(9):2672-7. PubMed ID: 21365239
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
Gionchetti P; Rizzello F; Venturi A; Brignola C; Ferretti M; Peruzzo S; Campieri M
Aliment Pharmacol Ther; 1997 Dec; 11(6):1053-7. PubMed ID: 9663829
[TBL] [Abstract][Full Text] [Related]
3. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository.
Kato S; Ishibashi A; Kani K; Yakabi K
Digestion; 2018; 97(1):59-63. PubMed ID: 29393142
[TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study.
Watanabe M; Nishino H; Sameshima Y; Ota A; Nakamura S; Hibi T
Aliment Pharmacol Ther; 2013 Aug; 38(3):264-73. PubMed ID: 23734840
[TBL] [Abstract][Full Text] [Related]
5. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
Marteau P; Crand J; Foucault M; Rambaud JC
Gut; 1998 Feb; 42(2):195-9. PubMed ID: 9536943
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.
Lucidarme D; Marteau P; Foucault M; Vautrin B; Filoche B
Aliment Pharmacol Ther; 1997 Apr; 11(2):335-40. PubMed ID: 9146772
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole in the treatment of chronic radiation proctitis: clinical trial.
Cavcić J; Turcić J; Martinac P; Jelincić Z; Zupancić B; Panijan-Pezerović R; Unusić J
Croat Med J; 2000 Sep; 41(3):314-8. PubMed ID: 10962052
[TBL] [Abstract][Full Text] [Related]
8. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
Gionchetti P; Rizzello F; Venturi A; Ferretti M; Brignola C; Miglioli M; Campieri M
Dis Colon Rectum; 1998 Jan; 41(1):93-7. PubMed ID: 9510317
[TBL] [Abstract][Full Text] [Related]
10. [The usefulness of mesalazine suppositories for the treatment of lymphoid follicular proctitis].
Seo GS; Choi SC; Jo EY; Choi CS; Kim JW; Kim TH; Yun KJ; Nah YH
Korean J Gastroenterol; 2006 Jun; 47(6):420-4. PubMed ID: 16809948
[TBL] [Abstract][Full Text] [Related]
11. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.
d'Albasio G; Paoluzi P; Campieri M; Bianchi Porro G; Pera A; Prantera C; Sturniolo GC; Miglioli M
Am J Gastroenterol; 1998 May; 93(5):799-803. PubMed ID: 9625131
[TBL] [Abstract][Full Text] [Related]
12. Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis.
Pica R; Paoluzi OA; Iacopini F; Marcheggiano A; Crispino P; Rivera M; Bella A; Consolazio A; Paoluzi P
Inflamm Bowel Dis; 2004 Nov; 10(6):731-6. PubMed ID: 15626890
[TBL] [Abstract][Full Text] [Related]
13. Formalin therapy for hemorrhagic radiation proctitis.
Dziki Ł; Kujawski R; Mik M; Berut M; Dziki A; Trzciński R
Pharmacol Rep; 2015 Oct; 67(5):896-900. PubMed ID: 26398382
[TBL] [Abstract][Full Text] [Related]
14. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
Richter JM; Kushkuley S; Barrett JA; Oster G
Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.
Heyman MB; Kierkus J; Spénard J; Shbaklo H; Giguere M
Inflamm Bowel Dis; 2010 Nov; 16(11):1931-9. PubMed ID: 20848454
[TBL] [Abstract][Full Text] [Related]
16. Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed.
Kim TO; Song GA; Lee SM; Kim GH; Heo J; Kang DH; Cho M
Int J Colorectal Dis; 2008 Jun; 23(6):629-33. PubMed ID: 18327596
[TBL] [Abstract][Full Text] [Related]
17. Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis.
Yamamoto T; Shimoyama T; Matsumoto K
Aliment Pharmacol Ther; 2015 Sep; 42(5):549-58. PubMed ID: 26140337
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Andus T; Kocjan A; Müser M; Baranovsky A; Mikhailova TL; Zvyagintseva TD; Dorofeyev AE; Lozynskyy YS; Cascorbi I; Stolte M; Vieth M; Dilger K; Mohrbacher R; Greinwald R;
Inflamm Bowel Dis; 2010 Nov; 16(11):1947-56. PubMed ID: 20310020
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic therapy for radiation proctitis-induced hemorrhage in patients with prostatic carcinoma using argon plasma coagulator application.
Venkatesh KS; Ramanujam P
Surg Endosc; 2002 Apr; 16(4):707-10. PubMed ID: 11972221
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: a multicenter randomized study.
Lamet M; Ptak T; Dallaire C; Shah U; Grace M; Spenard J; de Montigny D;
Inflamm Bowel Dis; 2005 Jul; 11(7):625-30. PubMed ID: 15973115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
